葡萄糖限制:癌症治疗中的双刃剑
Shenglong Xia1, Dingjiacheng Jia1
1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310058, China; Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang Province, 310058, China.
Trends in cancer
|September 6, 2025
概括
葡萄糖限制减缓了原发性瘤的生长,但通过创造免疫抑制环境,意外地增加了肺转移. 这突显了葡萄糖代谢在癌症进展和治疗策略中的复杂作用.
科学领域:
- 癌症学
- 癌症新陈代谢
- 免疫学
背景情况:
- 葡萄糖限制是一种限制瘤生长的常见策略.
- 葡萄糖代谢对癌症转移的确切影响尚不完全理解.
研究的目的:
- 研究葡萄糖限制对原发性瘤生长和转移的影响.
- 阐明转移过程中葡萄糖限制引起的变化的机制.
主要方法:
- 使用小鼠模型研究在葡萄糖限制下的主要瘤生长和肺转移.
- 分析了前转移性的免疫细胞组成.
- 评估了巨细胞和自然杀手细胞在转移中的作用.
主要成果:
- 葡萄糖限制抑制了主要瘤的生长.
- 相反,葡萄糖限制显著促进了肺转移.
- 通过巨细胞积累和NK细胞缺陷特征的前转移性位 (PMN) 被确定.
- 这种PMN在葡萄糖限制下促进转移至关重要.
结论:
- 葡萄糖限制在癌症中表现出双重作用,抑制主要瘤,同时促进肺转移.
- 免疫抑制性PMN的形成是葡萄糖限制增强转移的一个关键机制.
- 这些发现需要重新评估癌症治疗中的葡萄糖代谢调节策略.
相关概念视频
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Overview of Carbohydrate Metabolism
1.7K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.7K


